Ahlberg, M., Neovius, M., Saltvedt, S., Söderling, J., Pettersson, K., Brandkvist, C., & Stephansson, O. (2020). Association of SARS-CoV-2 Test Status and Pregnancy Outcomes. JAMA, 324(17), 1782–1785. https://doi.org/10.1001/jama.2020.19124
Akhtar, H., Patel, C., Abuelgasim, E., & Harky, A. (2020). COVID-19 (SARS-CoV-2) Infection in Pregnancy: A Systematic Review. Gynecologic and Obstetric Investigation, 85(4), 295–306. https://doi.org/10.1159/000509290
Atyeo, C., DeRiso E. A., Davis C., Bordt E. A., DeGuzman R. M., Shook L. L., et al. COVID-19 mRNA vaccines drive differential Fc-functional profiles in pregnant, lactating, and non-pregnant women | bioRxiv. Retrieved September 22, 2021, from https://www.biorxiv.org/content/10.1101/2021.04.04.438404v1
Baergen, R. N., & Heller, D. S. (2020). Placental Pathology in Covid-19 Positive Mothers: Preliminary Findings. Pediatric and Developmental Pathology: The Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society, 23(3), 177–180. https://doi.org/10.1177/1093526620925569
Beharier, O., Plitman Mayo, R., Raz, T., Nahum Sacks, K., Schreiber, L., Suissa-Cohen, et al. (2021). Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine. The Journal of Clinical Investigation, 131(13), 150319. https://doi.org/10.1172/JCI150319
Bookstein Peretz, S., Regev, N., Novick, L., Nachshol, M., Goffer, E., Ben-David, A., et al. (2021). Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine. Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 58(3), 450–456. https://doi.org/10.1002/uog.23729
Bowman, C. J., Bouressam, M., Campion, S. N., Cappon, G. D., Catlin, N. R., Cutler, M. W., et al. (2021). Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine. Reproductive Toxicology (Elmsford, N.Y.), 103, 28–35. https://doi.org/10.1016/j.reprotox.2021.05.007
Brillo, E., Tosto, V., Gerli, S., & Buonomo, E. (2021). COVID-19 vaccination in pregnancy and postpartum. The Journal of Maternal-Fetal & Neonatal Medicine, 0(0), 1–20. https://doi.org/10.1080/14767058.2021.1920916
Chervenak, F. A., McCullough, L. B., Bornstein, E., Johnson, L., Katz, A., McLeod-Sordjan, R., et al. (2021). Professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients. American Journal of Obstetrics and Gynecology, 224(5), 470–478. https://doi.org/10.1016/j.ajog.2021.01.027
Collier, A.-R. Y., McMahan, K., Yu, J., Tostanoski, L. H., Aguayo, R., Ansel, J., et al. (2021). Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women. JAMA, 325(23), 2370–2380. https://doi.org/10.1001/jama.2021.7563
Dagan, N., Barda, N., Biron-Shental, T., Makov-Assif, M., Key, C., Kohane, I. S., Hernán, M. A., Lipsitch, M., Hernandez-Diaz, S., Reis, B. Y., & Balicer, R. D. (2021). Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nature Medicine. https://doi.org/10.1038/s41591-021-01490-8
Food and Drug Administration (FDA). (2021a). https://www.fda.gov/home. Accessed August 11, 2021.
Food and Drug Administration (FDA). (2021b). Janssen COVID-19 Vaccine. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/janssen-covid-19-vaccine. Accessed August 1 2021.
Goldshtein, I., Nevo, D., Steinberg, D. M., Rotem, R. S., Gorfine, M., Chodick, G., & Segal, Y. (2021). Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women. JAMA, 326(8), 728–735. https://doi.org/10.1001/jama.2021.11035
Gray, K. J., Bordt, E. A., Atyeo, C., Deriso, E., Akinwunmi, B., Young, N., et al. (2021). Coronavirus disease 2019 vaccine response in pregnant and lactating women: A cohort study. American Journal of Obstetrics and Gynecology, 225(3), 303.e1-303.e17. https://doi.org/10.1016/j.ajog.2021.03.023
Gurol-Urganci, I., Jardine, J. E., Carroll, F., Draycott, T., Dunn, G., Fremeaux, A., et al. (2021). Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: National cohort study. American Journal of Obstetrics and Gynecology, S0002-9378(21)00565-2. https://doi.org/10.1016/j.ajog.2021.05.016
Handley, S. C., Mullin, A. M., Elovitz, M. A., Gerson, K. D., Montoya-Williams, D., Lorch, S. A., & Burris, H. H. (2021). Changes in Preterm Birth Phenotypes and Stillbirth at 2 Philadelphia Hospitals During the SARS-CoV-2 Pandemic, March-June 2020. JAMA, 325(1), 87–89. https://doi.org/10.1001/jama.2020.20991
Hcini, N., Maamri, F., Picone, O., Carod, J.-F., Lambert, V., Mathieu, M., et al. (2021). Maternal, fetal and neonatal outcomes of large series of SARS-CoV-2 positive pregnancies in peripartum period: A single-center prospective comparative study. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 257, 11–18. https://doi.org/10.1016/j.ejogrb.2020.11.068
Head Zauche, L., Wallace, B., Smoots, A. N., Olson, C. K., Oduyebo, T., Kim, S. Y., et al. (2021). Receipt of mRNA COVID-19 vaccines preconception and during pregnancy and risk of self-reported spontaneous abortions, CDC v-safe COVID-19 Vaccine Pregnancy Registry 2020–21. Research Square, rs.3.rs-798175. https://doi.org/10.21203/rs.3.rs-798175/v1
Jering, K. S., Claggett, B. L., Cunningham, J. W., Rosenthal, N., Vardeny, O., Greene, M. F., & Solomon, S. D. (2021). Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19. JAMA Internal Medicine, 181(5), 714–717. https://doi.org/10.1001/jamainternmed.2020.9241
Kadali, R. A. K., Janagama, R., Peruru, S. R., Racherla, S., Tirumala, R., Madathala, R. R., & Gajula, V. (2021). Adverse effects of COVID-19 messenger RNA vaccines among pregnant women: A cross-sectional study on healthcare workers with detailed self-reported symptoms. American Journal of Obstetrics and Gynecology, S0002-9378(21)00638-4. https://doi.org/10.1016/j.ajog.2021.06.007
Khalil, A., von Dadelszen, P., Draycott, T., Ugwumadu, A., O’Brien, P., & Magee, L. (2020). Change in the Incidence of Stillbirth and Preterm Delivery During the COVID-19 Pandemic. JAMA. https://doi.org/10.1001/jama.2020.12746
Lokken, E. M., Huebner, E. M., Taylor, G. G., Hendrickson, S., Vanderhoeven, J., Kachikis, A., et al. (2021). Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State. American Journal of Obstetrics and Gynecology, 225(1), 77.e1-77.e14. https://doi.org/10.1016/j.ajog.2020.12.1221
Martinez-Portilla, R. J. (2021). Vertical transmission of coronavirus disease 2019. American Journal of Obstetrics and Gynecology, 224(3), 328–329. https://doi.org/10.1016/j.ajog.2020.11.013
Metz, T. D., Clifton, R. G., Hughes, B. L., Sandoval, G., Saade, G. R., Grobman, W. A., et al. (2021). Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19). Obstetrics and Gynecology, 137(4), 571–580. https://doi.org/10.1097/AOG.0000000000004339
Mithal, L. B., Otero, S., Shanes, E. D., Goldstein, J. A., & Miller, E. S. (2021). Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy. American Journal of Obstetrics and Gynecology, 225(2), 192–194. https://doi.org/10.1016/j.ajog.2021.03.035
Ministry of Health and Family Welfare. Government of India (MOHFW). Operational Guidance for covid 19 vaccination in pregnant women. Accessed August 12, 2021
Morris, R. S. (2021). SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility. F&S Reports, 2(3), 253–255. https://doi.org/10.1016/j.xfre.2021.05.010
Orvieto, R., Noach-Hirsh, M., Segev-Zahav, A., Haas, J., Nahum, R., & Aizer, A. (2021). Does mRNA SARS-CoV-2 vaccine influence patients’ performance during IVF-ET cycle? Reproductive Biology and Endocrinology: RB&E, 19(1), 69. https://doi.org/10.1186/s12958-021-00757-6
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018). mRNA vaccines—A new era in vaccinology. Nature Reviews. Drug Discovery, 17(4), 261–279. https://doi.org/10.1038/nrd.2017.243
Pfizer-BioNTech COVID-19 vaccine. (2021a). Pfizer accidenatal Vaccines and Related Biological Products Advisory Committee Meeting December 10, 2020. https://www.fda.gov/media/144245/pdf/download. Accessed August 11, 2021.
Pfizer-BioNTech COVID-19 vaccine. (2021b). Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women. (2021b). https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-commence-global-clinical-trial-evaluate. Accessed August 1, 2021
Pineles, B. L., Alamo, I. C., Farooq, N., Green, J., Blackwell, S. C., Sibai, B. M., & Parchem, J. G. (2020). Racial-ethnic disparities and pregnancy outcomes in SARS-CoV-2 infection in a universally-tested cohort in Houston, Texas. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 254, 329–330. https://doi.org/10.1016/j.ejogrb.2020.09.012
Prabhu, M., Murphy, E. A., Sukhu, A. C., Yee, J., Singh, S., Eng, D., et al. (2021). Antibody Response to Coronavirus Disease 2019 (COVID-19) Messenger RNA Vaccination in Pregnant Women and Transplacental Passage Into Cord Blood. Obstetrics and Gynecology, 138(2), 278–280. https://doi.org/10.1097/AOG.0000000000004438
Rac, H., Gould, A. P., Eiland, L. S., Griffin, B., McLaughlin, M., Stover, K. R., Bland, C. M., & Bookstaver, P. B. (2019). Common Bacterial and Viral Infections: Review of Management in the Pregnant Patient. The Annals of Pharmacotherapy, 53(6), 639–651. https://doi.org/10.1177/1060028018817935
Regulatory approval of Vaxzevria (previously COVID-19 Vaccine AstraZeneca). GOV.UK. https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca. Retrieved September 20, 2021
Rottenstreich, A., Zarbiv, G., Oiknine-Djian, E., Zigron, R., Wolf, D. G., & Porat, S. (2021). Efficient maternofetal transplacental transfer of anti- SARS-CoV-2 spike antibodies after antenatal SARS-CoV-2 BNT162b2 mRNA vaccination. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, ciab266. https://doi.org/10.1093/cid/ciab266
Schoenwolf, Bleyl, B., Francis-West. (2021).Fetal development and fetus as a patient In: Larsen’s Embryology (Sixth edition). Elsevier.
Shanes, E. D., Otero, S., Mithal, L. B., Mupanomunda, C. A., Miller, E. S., & Goldstein, J. A. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination in Pregnancy: Measures of Immunity and Placental Histopathology. Obstetrics and Gynecology, 138(2), 281–283. https://doi.org/10.1097/AOG.0000000000004457
Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., et al. (2021). Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. The New England Journal of Medicine, 384(24), 2273–2282. https://doi.org/10.1056/NEJMoa2104983
Stowe, J., Smith, H., Thurland, K., Ramsay, M. E., Andrews, N., & Ladhani, S. N. (2021). Stillbirths During the COVID-19 Pandemic in England, April-June 2020. JAMA, 325(1), 86–87. https://doi.org/10.1001/jama.2020.21369
Theiler, R. N., Wick, M., Mehta, R., Weaver, A. L., Virk, A., & Swift, M. (2021). Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy. American Journal of Obstetrics & Gynecology MFM, 3(6), 100467. https://doi.org/10.1016/j.ajogmf.2021.100467
Vivanti, A. J., Vauloup-Fellous, C., Prevot, S., Zupan, V., Suffee, C., Do Cao, J., et al. (2020). Transplacental transmission of SARS-CoV-2 infection. Nature Communications, 11(1), 3572. https://doi.org/10.1038/s41467-020-17436-6
World Health Organization. (2021a). Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under emergency use listing: Interim guidance, 8 January 2021 (WHO/2019-nCoV/vaccines/SAGE_recommendation/BNT162b2/2021.1). World Health Organization. https://apps.who.int/iris/handle/10665/338484. Accessed August 11, 2021
World Health Organization. (2021b). Background document on the mRNA-1273 vaccine (Moderna) against COVID-19., from https://www.who.int/publications-detail-redirect/background-document-on-the-mrna-1273-vaccine-(moderna)-against-covid-19. Accessed October 7, 2021
World Health Organization. (2021c). Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID19 developed by Oxford University and AstraZeneca: Interim guidance, 10 February 2021 (WHO/2019-nCoV/vaccines/SAGE_recommendation/AZD1222/2021.1). World Health Organization. https://apps.who.int/iris/handle/10665/339477. Accessed August 11, 2021.
World Health Organization. (2021d). Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine. https://www.who.int/publications-detail-redirect/WHO-2019-nCoV- vaccines-SAGE-recommendation-Ad26.COV2.S-2021.1. Accessed August 12, 2021.
Zdanowski, W., & Waśniewski, T. (2021). Evaluation of SARS-CoV-2 Spike Protein Antibody Titers in Cord Blood after COVID-19 Vaccination during Pregnancy in Polish Healthcare Workers: Preliminary Results. Vaccines, 9(6), 675. https://doi.org/10.3390/vaccines9060675
Zhang, H., & Zhang, H. (2021). Entry, egress and vertical transmission of SARS-CoV-2. Journal of Molecular Cell Biology, 13(3), 168–174. https://doi.org/10.1093/jmcb/mjab013